Primary Job Title Board of Directors Primary Organization 
Idenix Pharmaceuticals
Gender Female
LinkedIn View on LinkedIn
Tamar Howson has served as a director since March 2010. Prior to joining JSB-Partners, Ms. Howson was executive vice president of business development at Lexicon Pharmaceuticals where she led the company's partnering and licensing efforts.
From 2001 to 2007, Tamar was senior vice president corporate and business development at Bristol
Myers Squibb overseeing M&A, licensing and research collaborations across all businesses.
In 2000 and 2001, Ms. Howson served as a business development and strategy consultant to biotechnology companies in the United States and in Europe.
Ms. Howson worked at SmithKline Beecham from 1991 to 2000, where she was senior vice president and director of business development, responsible for worldwide in-licensing and business development. She also managed SR One, SmithKline Beecham's $100 million venture capital fund.
Before joining SmithKline Beecham, Ms. Howson served as vice president, venture investments at Johnson Associates, a venture capital firm, and earlier as director, worldwide business development and licensing for Squibb Corporation.
In 1999, Ms. Howson received the Healthcare Businesswomen's Association "Woman of the Year" Award. Ms. Howson currently serves on the board of S*Bio Pte Ltd., a consultant to Pitnago Venture Fund and is a member of the advisory board to Triana Venture Partners.
She previously served on the boards of Ariad Pharmaceuticals, SkyPharma, NPS Pharma, Targacept, and HBA.
Ms. Howson holds an M.B.A from Columbia University, a M.S. from City College of New York and a B.S. in Chemical Engineering from the Technion in Israel.
